Key result
Type I diabetes mellitus was associated with decreased beta-adrenergic sensitivity, requiring a higher isoproterenol dose to raise heart rate by 25 beats/min compared to normal subjects.
Why the study?
Does beta-adrenergic sensitivity differ in insulin-dependent diabetic patients compared to normal subjects?
Observational (n=44)
Does beta-adrenergic sensitivity differ in insulin-dependent diabetic patients compared to normal subjects?
Patients with type I diabetes mellitus exhibit diminished beta-adrenergic sensitivity compared to normal subjects, which correlates with age and disease duration.
Answers are grounded in this paper and cite their sources.
Reduced beta-adrenergic sensitivity may alter responses to adrenergic agents in type 1 diabetes; leaves open effects on cardiovascular outcomes.
To study beta-adrenergic sensitivity in diabetes mellitus, we performed isoproterenol sensitivity tests in 34 insulin-dependent diabetic patients and 10 age-matched normal subjects. beta-adrenergic sensitivity [defined as the dose of isoproterenol required to increase the resting heart rate by 25 beat/min, (I25)] was significantly higher in the diabetic group (4.07 +/- 1.4 micrograms, mean +/- SD) than in the normal group (2.02 +/- 1.49 micrograms). A comparison of I25 of normal subjects and diabetic patients as a function of age showed that the latter were significantly less sensitive to beta-adrenergic stimulation at all ages (P less than 0.01). In diabetic patients, beta-adrenergic sensitivity also increased with the duration of diabetes (r = 0.64, P less than 0.0005), but the correlation was stronger when the age of the patients and the duration of the diabetes were both taken into consideration (r = 0.72, P less than 0.0005). We conclude that beta-adrenergic sensitivity is diminished in patients with type I diabetes mellitus of all ages.
No takes yet. Share an insight, caveat, or question.
Berlin et al. (1986) conducted an observational in Insulin-dependent diabetes mellitus (n=44). Type I diabetes mellitus vs. Age-matched normal subjects was evaluated on Dose of isoproterenol required to increase the resting heart rate by 25 beat/min (I25) (p=<0.01). Type I diabetes mellitus was associated with decreased beta-adrenergic sensitivity, requiring a higher isoproterenol dose to raise heart rate by 25 beats/min compared to normal subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: